|
|
In order to further expand the market, improve the product quality, create the brand of YOLOO, and realize the sales target of five billion yuan, Yoloo started the strategic plan of building the new production plant in 2014. Laoting Yoloo Bio-technology Co., Ltd was established in Laoting economic development zone, Hebei in June 2015. After two years’ intensive project construction, the new production plant has been completed and has put into production. Laoting Yoloo Bio-technology Co., Ltd. is the independent legal person subsidiary wholly owned by Beijing Yoloo Bio-Technology Corp., Ltd. With more than 3,000 square meters of modern R&D center and 30 persons’ R&D team, Laoting Yoloo mainly focuses on developing and producing environmental friendly green pesticide mixtures. Laoting Yoloo has invested 400 million yuan to create the world-class production base and it has domestic first-class fully automatic production equipment and a professional team with more than 10 years’ experience of production management. With 30 liquid production lines, 23 solid production lines, we can fully meet the production needs of different formulation type including SL, OD, SC,ME, SE, WDG, WP, EC and so on. Our existing products covered four categories including insecticide, fungicide, herbicide and plant growth regulator, totally more than 200 kinds of products. Pesticide Plant Mudanjiang Bioseen Bio-technology Co., Ltd. was established in November 2009, focusing on the production of biological veterinary drugs, feed additives and other raw materials. The company covers a total area of 76,000 square meters. There are more than 30 factories and buildings, with a construction area of over 22,000 square meters. It employs experienced senior technical personnel in microbial fermentation, and cooperates closely with the Institute of Microbiology of the Chinese Academy of Sciences, Beijing University of Technology, Northeast Agricultural University, Mudanjiang Normal University, Mudanjiang Medical College and other colleges and universities. Veterinary Drug Plant Joint R&D of new products and technologies endows the company distinct technological advantages in biological industrialization. The company has won the Specialized and Sophisticated SMEs of Heilongjiang Province, obtained the high-tech enterprise certificate on July 18, 2012, and passed the re-examination in 2015 and 2018. At present, the company holds 28 authorized national patents, including 22 invention patents and 6 utility model patents. In addition, more than 10 invention patents have been accepted and are under substantive examination. The company also has obtained veterinary drug GMP production certificates following on-site inspections in 2014 and 2019 and 2024. Therefore, Mudanjiang Bioseen is a typical technology-intensive enterprise in sustainable biotechnology high-tech projects. |